Akso Health Group
Akso Health Group operates as a health care provider and services company, generating revenue through its disclosed customer base.
Business. Akso Health Group (AHG.O) is a health care provider and services company listed on the NASDAQ. The firm operates within the Health Care Providers & Services industry, generating revenue through service-based models. Specific details regarding operating segments, headquarters location, and geographic presence are not provided in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ2 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Akso Health Group (AHG.O) is a health care provider and services company listed on the NASDAQ. The firm operates within the Health Care Providers & Services industry, generating revenue through service-based models. Specific details regarding operating segments, headquarters location, and geographic presence are not provided in the available data.
(a) Akso Health Group maintains a conservative capital structure with a debt-to-equity ratio of 0.0, indicating no recorded interest-bearing debt relative to equity. The balance sheet shows total assets of $214,953,325, funded primarily by total equity of $199,119,145 and total liabilities of $15,802,189. Liquidity is supported by cash and equivalents of $176,229,874, which represents a significant portion of total assets. Operating cash flow stands at $1,177,163, while capital expenditure is minimal at $154,460, suggesting low reinvestment requirements in the current period.
(b) Profitability metrics indicate significant operational losses, with a net income of -$134,977,369 against revenue of $14,777,798. The company reports a negative gross profit of -$281,526, implying that direct costs of revenue exceeded sales in this period. Return on equity is -0.6779 and return on assets is -0.6279, reflecting the erosion of shareholder value due to operating losses. Without cohort median data for comparison, these returns are assessed as negative relative to standard industry benchmarks for profitable health care providers.
- The company holds a strong cash position of $176.2 million with zero debt, providing a buffer against operational losses.
- Significant customer concentration exists, with the top four clients accounting for over 63% of revenue.
- Operational performance is weak, with negative gross profit and substantial net losses of $135 million.
- Dilution risk is assessed as low, with no immediate flags for share issuance.
- Lack of historical data prevents trend analysis, but current metrics suggest a need for operational restructuring.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Return On Equitynet_income / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Return On Assetsnet_income / total_assets
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Akso Health Group Market data — financials · 2026-07-26
- reconciler_enqueue (reconciler) on AHG.O · 2026-07-26
- Akso Health Group HA canonical relationships · 2026-07-26
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Leadership
- Xiaobo AnChairman of the Board, Chief Executive Officer
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Cost of revenue (annual): USD 13.84MUnknown
- Revenue (annual): USD 13.83MUnknown
- Pre-tax income (annual): USD -20.7MUnknown
- EPS (diluted) (annual): USD-PER-SHARES 0Unknown
- Operating cash flow (annual): USD -12.79MUnknown
- Net income (annual): USD -18.67MUnknown
- Gross profit (annual): USD -11.31KUnknown
- Total operating expenses (annual): USD 20.69MUnknown
- Operating income (annual): USD -20.7MUnknown
- Capex (annual): USD 1.64KUnknown
- EPS (basic) (annual): USD-PER-SHARES 0Unknown
- Net income (annual): USD -134.98MUnknown
- Gross profit (annual): USD -281.53KUnknown
- Operating income (annual): USD -166.3MUnknown
- Revenue (annual): USD 14.78MUnknown
- Cost of revenue (annual): USD 15.06MUnknown
- Pre-tax income (annual): USD -166.27MUnknown
- Operating cash flow (annual): USD 1.18MUnknown
- Capex (annual): USD 154.46KUnknown
- Total operating expenses (annual): USD 166.02MUnknown